"Voriconazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A triazole antifungal agent that specifically inhibits STEROL 14-ALPHA-DEMETHYLASE and CYTOCHROME P-450 CYP3A.
| Descriptor ID |
D065819
|
| MeSH Number(s) |
D03.383.129.799.950
|
| Concept/Terms |
UK 109,496- UK 109,496
- UK-109,496
- UK109,496
- UK-109496
- UK109496
- UK 109496
|
Below are MeSH descriptors whose meaning is more general than "Voriconazole".
Below are MeSH descriptors whose meaning is more specific than "Voriconazole".
This graph shows the total number of publications written about "Voriconazole" by people in this website by year, and whether "Voriconazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 4 | 4 |
| 2004 | 0 | 4 | 4 |
| 2005 | 0 | 6 | 6 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 5 | 5 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 3 | 3 |
| 2012 | 0 | 4 | 4 |
| 2013 | 0 | 2 | 2 |
| 2014 | 3 | 2 | 5 |
| 2015 | 4 | 1 | 5 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 2 | 3 |
| 2018 | 5 | 5 | 10 |
| 2019 | 0 | 2 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Voriconazole" by people in Profiles.
-
Ivosidenib significantly reduces triazole levels in patients with acute myeloid leukemia and myelodysplastic syndrome. Cancer. 2024 Jun 01; 130(11):1964-1971.
-
Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies. Clin Infect Dis. 2022 10 29; 75(9):1503-1510.
-
How different is invasive fusariosis in pediatric patients than in adults? A systematic review. Curr Opin Infect Dis. 2021 12 01; 34(6):619-626.
-
Correlation of serum galactomannan antigen with diagnosis and response to voriconazole in orbital/sino-orbital invasive aspergillosis. Int Ophthalmol. 2021 08; 41(8):2635-2638.
-
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial. Lancet. 2021 02 06; 397(10273):499-509.
-
Voriconazole-induced periostitis in stem cell transplant patient. Infection. 2020 10; 48(5):809-810.
-
Cost-Effectiveness of Antifungal Supplementation of Corneal Cold Storage Media. Ophthalmology. 2020 05; 127(5):582-588.
-
Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for In Vitro Eradication of Candida auris Biofilm. Antimicrob Agents Chemother. 2019 07; 63(7).
-
Risk Factors and Outcomes of Nonmelanoma Skin Cancer in Children and Young Adults. J Pediatr. 2019 08; 211:152-158.
-
Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies. BMC Infect Dis. 2018 Dec 13; 18(1):656.